Loading insider details...
Beta
Latest Form 4 (Jul 31, 2026): Sale of 3,673 KNSA shares, $299.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 3,673 | $299.1K |
| Jun 2, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,799 | n/a |
| Jun 1, 2026 | CASTLE BIOSCIENCES INC (CSTL) | Grant/Award | 11,766 | n/a |
| May 27, 2026 | CASTLE BIOSCIENCES INC (CSTL) | Exercise/Conversion | 13,667 | n/a |
| Mar 9, 2026 | CASTLE BIOSCIENCES INC (CSTL) | Exercise/Conversion | 4,748 | $16.0K |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 3,173 | n/a |
| May 23, 2025 | CASTLE BIOSCIENCES INC (CSTL) | Exercise/Conversion | 8,673 | n/a |
| Jun 7, 2024 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Exercise/Conversion | 4,373 | n/a |
| May 29, 2024 | CASTLE BIOSCIENCES INC (CSTL) | Exercise/Conversion | 8,636 | n/a |
| May 28, 2024 | CASTLE BIOSCIENCES INC (CSTL) | Grant/Award | 8,673 | n/a |